1Burke AP,Farb A,Maleom GT,et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly[J]. N Engl J Med, 1997,336(18) : 1276-1282.
2Bulhak A, Sjoquist PO, Pernow J. Rosuvastatin protects themyocardium against ischemia-reperfusion injury via inhibition of GGPP synthesis[J]. Cardiovasc J S Afr, 2004,15 (4 Suppl 1 ) : S11.
3Spertus JA, Radford MJ, Every NR, et al. Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association/ American College of Cardiology First Scientific Forum onQuality of Care and Outcomes Research in Cardiovascular Disease and Stroke[J]. J Am Coil Cardiol, 2003,41 (9) : 1653- 1663.
1James E. Jordan, Zhi-Qing Zhao, Jakob Vinten-Johansen .The role of neutrophils in myocardial ischemia-reperfusion injury .Cardiovascular Research , 1999,43:860～878.
2Frangogiannis NG,Smith CW,Entman ML.The inflammatory response in myocardial infarction.Cardiovasc Res,2002,53(1):31～47.
3Naidu BV, Woolley SM, Farivar AS, et al.Simvastatin ameliorates injury in anexperimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg,2003,126(2):482～489.
4Yokota N, Odonnell M, Daniels F, et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol, 2003,23(1): 13～17.
5Birnbaum Y, Ashitkov T, Uretsky BF, et al. Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther, 2003, 17(1): 25～30.
6Tiefenbacher CP, Kapitza J, Dietz V, et al. Reduction of myocardial infarct size by fluvastatin.Am J Physiol Heart Circ Physiol, 2003, 285(1): 59～64.
7Metzler B, Mair J, Lercher A, et al. Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1. Cardiovasc Res, 2001, 49 (2): 399～407.
8Hartman JC, Anderson DC, Wiltse AL, et al. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. Cardiovasc Res, 1995, 30(1):47～54.
3Schulze CJ, Wang W, Suarez-Pinzon WL, et al. Imbalancebetween tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial E correction of myoctardial ischemia-reperfusion injury [ J]. Circulation, 2003,107(19) :2487-2492.
4Zhang LP, Yang CY, Wang YP, et al. Protective effect of polydatin against ischemia/reperfusion injury in rat heart [J]. Sheng Li Xue Bao,2008,60(2) :161-168.
5Liu H,Bai XB, Shi S, et al. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats[J]. J Pharm Pharmacol, 2009,61 (2) : 207 - 212.
6Reiter R J, Tan DX, O.i W, et al.Pharmacology and physiology of melatonin in the recduction of oxidative stress in vivo[J], Biol Sigals Recept,2000,9(3/4): 160-171.
7Vasilieva E,KasyanovaO,ShpektorA.The antiplate|et effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level[J].Acute Card Care, 2008, 10 (3),181-184.
8Leonardi S, Thomas L, Neely ML, et al. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction[J]. J Am Coil Cardiol, 2012, 60(22): 2296-2304.
